{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-119494","form_type":"8-K","ticker":"IPSC","cik":"0001850119","company_name":"Century Therapeutics, Inc.","filed_at":"2025-12-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.808262+00:00","generated_at":"2026-05-16T13:50:10.946919+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Century Therapeutics appoints Dr. Murphy and Dr. Lee to Board, expanding from six to eight members","bullets":["Board expanded from six to eight directors; Dr. Murphy (Class III, term to 2027) and Dr. Lee (Class II, term to 2026) appointed.","Dr. Murphy brings life science investment experience; Dr. Lee brings corporate development and CFO background from biotech firms.","Each new director received an initial option grant of 88,000 shares vesting over 36 months and a $40,000 annual cash retainer.","Dr. Murphy joins Compensation and Nominating/Governance Committees; Dr. Lee joins Audit and Compensation Committees.","Appointments effective December 9, 2025; both deemed independent under Nasdaq rules."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-119494","json":"https://secwatch.observer/filing/0001104659-25-119494.json","markdown":"https://secwatch.observer/filing/0001104659-25-119494.md","text":"https://secwatch.observer/filing/0001104659-25-119494.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1850119/000110465925119494/0001104659-25-119494-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1850119/000110465925119494/tm2532966d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:50:10.946919+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}